181 related articles for article (PubMed ID: 16326920)
1. Inorganic mercury and methylmercury inhibit the Cav3.1 channel expressed in human embryonic kidney 293 cells by different mechanisms.
Tarabová B; Kurejová M; Sulová Z; Drabová M; Lacinová L
J Pharmacol Exp Ther; 2006 Apr; 317(1):418-27. PubMed ID: 16326920
[TBL] [Abstract][Full Text] [Related]
2. Effects of methylmercury on human neuronal L-type calcium channels transiently expressed in human embryonic kidney cells (HEK-293).
Peng S; Hajela RK; Atchison WD
J Pharmacol Exp Ther; 2002 Aug; 302(2):424-32. PubMed ID: 12130699
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of methylmercury and Hg(2+) on human neuronal N- and R-type high-voltage activated calcium channels transiently expressed in human embryonic kidney 293 cells.
Hajela RK; Peng SQ; Atchison WD
J Pharmacol Exp Ther; 2003 Sep; 306(3):1129-36. PubMed ID: 12805476
[TBL] [Abstract][Full Text] [Related]
4. Mercurial-induced alterations in neuronal divalent cation homeostasis.
Denny MF; Atchison WD
Neurotoxicology; 1996; 17(1):47-61. PubMed ID: 8784818
[TBL] [Abstract][Full Text] [Related]
5. Methylmercury affects multiple subtypes of calcium channels in rat cerebellar granule cells.
Sirois JE; Atchison WD
Toxicol Appl Pharmacol; 2000 Aug; 167(1):1-11. PubMed ID: 10936073
[TBL] [Abstract][Full Text] [Related]
6. Imatinib-mesylate blocks recombinant T-type calcium channels expressed in human embryonic kidney-293 cells by a protein tyrosine kinase-independent mechanism.
Cataldi M; Gaudino A; Lariccia V; Russo M; Amoroso S; di Renzo G; Annunziato L
J Pharmacol Exp Ther; 2004 Apr; 309(1):208-15. PubMed ID: 14718589
[TBL] [Abstract][Full Text] [Related]
7. Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide.
Todorovic SM; Jevtovic-Todorovic V; Mennerick S; Perez-Reyes E; Zorumski CF
Mol Pharmacol; 2001 Sep; 60(3):603-10. PubMed ID: 11502893
[TBL] [Abstract][Full Text] [Related]
8. Mammalian voltage-gated calcium channels are potently blocked by the pyrethroid insecticide allethrin.
Hildebrand ME; McRory JE; Snutch TP; Stea A
J Pharmacol Exp Ther; 2004 Mar; 308(3):805-13. PubMed ID: 14634047
[TBL] [Abstract][Full Text] [Related]
9. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel.
Freeze BS; McNulty MM; Hanck DA
Mol Pharmacol; 2006 Aug; 70(2):718-26. PubMed ID: 16699084
[TBL] [Abstract][Full Text] [Related]
10. Methylmercury increases intracellular concentrations of Ca++ and heavy metals in NG108-15 cells.
Hare MF; McGinnis KM; Atchison WD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1626-35. PubMed ID: 8371160
[TBL] [Abstract][Full Text] [Related]
11. High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation.
Tamm C; Duckworth J; Hermanson O; Ceccatelli S
J Neurochem; 2006 Apr; 97(1):69-78. PubMed ID: 16524380
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel gamma6 subunits are unique modulators of low voltage-activated (Cav3.1) calcium current.
Hansen JP; Chen RS; Larsen JK; Chu PJ; Janes DM; Weis KE; Best PM
J Mol Cell Cardiol; 2004 Dec; 37(6):1147-58. PubMed ID: 15572045
[TBL] [Abstract][Full Text] [Related]
13. Gating of the expressed T-type Cav3.1 calcium channels is modulated by Ca2+.
Lacinová L; Kurejová M; Klugbauer N; Hofmann F
Acta Physiol (Oxf); 2006 Apr; 186(4):249-60. PubMed ID: 16634780
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term amiodarone treatments regulate Cav3.2 low-voltage-activated T-type Ca2+ channel through distinct mechanisms.
Yamashita N; Kaku T; Uchino T; Isomoto S; Yoshimatsu H; Ono K
Mol Pharmacol; 2006 May; 69(5):1684-91. PubMed ID: 16443692
[TBL] [Abstract][Full Text] [Related]
15. The immunosuppressive effect of methylmercury does not preclude development of autoimmunity in genetically susceptible mice.
Häggqvist B; Havarinasab S; Björn E; Hultman P
Toxicology; 2005 Mar; 208(1):149-64. PubMed ID: 15664442
[TBL] [Abstract][Full Text] [Related]
16. Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels.
Tao J; Hildebrand ME; Liao P; Liang MC; Tan G; Li S; Snutch TP; Soong TW
Mol Pharmacol; 2008 Jun; 73(6):1596-609. PubMed ID: 18292205
[TBL] [Abstract][Full Text] [Related]
17. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
18. Effects of mercurials on ligand- and voltage-gated ion channels: a review.
Sirois JE; Atchison WD
Neurotoxicology; 1996; 17(1):63-84. PubMed ID: 8784819
[TBL] [Abstract][Full Text] [Related]
19. Effect of protein tyrosine kinase inhibitors on the current through the Ca(V)3.1 channel.
Kurejová M; Lacinová L
Arch Biochem Biophys; 2006 Feb; 446(1):20-7. PubMed ID: 16386702
[TBL] [Abstract][Full Text] [Related]
20. Comparative action of methylmercury and divalent inorganic mercury on nerve terminal and intraterminal mitochondrial membrane potentials.
Hare MF; Atchison WD
J Pharmacol Exp Ther; 1992 Apr; 261(1):166-72. PubMed ID: 1560362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
